99mTc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model.

Article English OPEN
Miot-Noirault , Elisabeth ; David , Emmanuelle ; Vidal , Aurélien ; Peyrode , Caroline ; Besse , Sophie ; Dauplat , Marie-Mélanie ; Heymann , Marie-Françoise ; Gouin , François ; Chezal , Jean-Michel ; Heymann , Dominique ; Rédini , Françoise (2013)
  • Publisher: BioMed Central
  • Journal: EJNMMI Research, volume 3, pages 40-40 (issn: 2191-219X, eissn: 2191-219X)
  • Related identifiers: pmc: PMC3665493, doi: 10.1186/2191-219X-3-40
  • Subject: Proteoglycans | [ SDV.IB ] Life Sciences [q-bio]/Bioengineering | [ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/Imaging | Zoledronic acid | Chondrosarcoma | Short Communication | 99mTc-NTP 15-5 radiotracer

International audience; BACKGROUND: Since proteoglycans (PGs) appear as key partners in chondrosarcoma biology, PG-targeted imaging using the radiotracer 99mTc-N-[triethylammonium]-3-propyl-[15]ane-N5 (99mTc-NTP 15-5) developed by our group was previously demonstrated t... View more
  • References (13)
    13 references, page 1 of 2

    1. World Health Organization: Cartilage tumors. In Pathology and Genetics of Tumours of Soft Tissue and Bone. Edited by Fletcher CDM, Unni KK, Mertens F. Lyon: IARC; 2002:234-257 [Kleihues P, Sobin LH (Series Editors): World Health Organization Classification of Tumors].

    2. Velasco CR, Colliec-Jouault S, Redini F, Heymann D, Padrines M: Proteoglycans on bone tumor development. Drug Discov Today 2010, 13-14:553-560.

    3. Miot-Noirault E, Gouin F, Vidal A, Rapp M, Maublant J, Askienazy S, Chezal JM, Heymann D, Redini F, Moins N: First preclinical imaging of primary cartilage neoplasm and its local recurrence using 99mTc-NTP 15-5 radiotracer. J Nucl Med 2009, 50:1541-1547.

    4. Onishi AC, Hincker AM, Lee FY: Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets. Sarcoma 2011, 2011:381564.

    5. Moriceau G, Ory B, Gobin B, Verrecchia F, Gouin F, Blanchard F, Redini F, Heymann D: Therapeutic approach of primary bone tumours by bisphosphonates. Curr Pharm Des 2010, 16:2981-2987.

    6. Gouin F, Ory B, Rédini F, Heymann D: Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival. Int J Cancer 2006, 119:980-984.

    7. Streitbuerger A, Henrichs M, Ahrens H, Lanvers-Kaminzky C, Gouin F, Gosheger G, Hardes J: Cytotoxic effect of clodronate and zoledronate on the chondrosarcoma cell lines HTB-94 and CAL-78. Int Orthop 2011, 35:1369-1373.

    8. Grimaud E, Damiens C, Rousselle AV, Passuti N, Heymann D, Gouin F: Bone remodelling and tumor grade modifications induced by interactions between bone and swarm rat chondrosarcoma. Histol Histopathol 2002, 17:1103-1111.

    9. Odri GA, Dumoucel S, Picarda G, Battaglia S, Lamoureux F, Corradini N, Rousseau J, Tirode F, Laud K, Delattre O, Gouin F, Heymann D, Redini F: Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients. Cancer Res 2010, 70:7610-7619.

    10. Montella L, Addeo R, Faiola V, Cennamo G, Guarrasi R, Capasso E, Mamone R, Caraglia M, Del Prete S: Zoledronic acid in metastatic chondrosarcoma and advanced sacrum chordoma: two case reports. J Exp Clin Cancer Res 2009, 28:7.

  • Similar Research Results (4)
  • Metrics
    No metrics available
Share - Bookmark